Morris Animal Foundation's Golden Retriever Lifetime Study will help identify major nutritional, genetic and environmental risk factors for cancer and other important diseasesin dogs.
Displaying 1 - 7 of 32 Results
Researchers will determine if common heart medications are an effective adjunct therapy for dogs with hemangiosarcoma.
Researchers will identify potential treatment targets for B-cell chronic lymphocytic leukemia in dogs and ways to identify high-risk patients.
Researchers will explore metabolic drivers of cancer growth and look for new therapy targets for osteosarcoma, the most common type of bone cancer in dogs.
Researchers will determine if a promising new drug used to treat dogs with hemangiosarcoma would benefit dogs with other incurable cancers.
Researchers will investigate how hemangiosarcoma cells use cholesterol and lipids to promote tumor growth and look at ways to block tumor cells from using these metabolic fuels.
Researchers are investigating the effectiveness of a novel immunotherapy to help reduce metastatic disease (cancer spread) and prolong quality of life in dogs with osteosarcoma.